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Autoimmunity and the Liver: 
Mechanistic insights
 Positive AAB and high IgG
 Progressive inflammatory disorder
 Exclusion of other pathology 
(Wilson, HCV, HBV, NASH)
Autoimmune Hepatitis
Interface
hepatitis
Autoimmune Hepatitis
 Anti-smooth muscle (SMA)  &
 Anti-nuclear (ANA) autoantibodies
Autoimmune Hepatitis - Type 1
Liver Kidney 
Microsomal antibody
Autoimmune Hepatitis - Type 2
Liver Cytosol
Type 1 antibody
LC-1 LKM-1
Homogenous anti-nuclear pattern on HEp2 cells

Anti-nuclear (ANA) antibodies 
No signle AIH-1 specific ANA 
antigen
Targets: Centromere
Histones
Chromatin 
dsDNA
Ribonucleoproteins
Pier Luigi Meroni, Peter H Schur
ANA screening: an old test with new
Recommendations
Ann Rheum Dis 2010;69:1420–1422

Anti-smooth muscle (SMA)
VGT (actin) pattern
V T
G G
Thomas Splettstoesser
Actin filament - atomic model


 Elevated ALT
 histology: interface and lobular 
hepatitis, multilobular collapse
 Anti-mitochondrial Ab positive at 1/800
 Hep B, Hep C  and other viral infections 
excluded
 King’s testing: anti-LKM-1 positive, 
Titre >1:10.240 
 Repeat test confirms: anti-mitochondrial 
Ab positive at a titre of 1/800
 Elisa: anti-cytochrome P450 2D6, positive
out of scale
Misdiagnosis
LKM-1 AMA
Antimitochondrial antibody (AMA)
Commercial kits available
Molecular target:
PDC-E2
AMA
Commercial kits available
Molecular target:
CYP2D6
LKM-1
20 yrs old female, Caucasian, 
Nurse, from Southern California,
Non specific symptoms
Hepatomegaly-Splenomegaly
Unexplained increase of IgG
5x upper NV transaminases
ANA, SMA, AMA negative
Liver biopsy: cirrhosis
Clinical Case -1 
DIAGNOSIS: Cryptogenic hepatitis
ReTest: 
anti-LKM
1 (1/640
)
Diagnosis
: Autoim
mune He
patitis t
ype 2
Outcome
: Liver T
ransplan
ation - A
live
16 yrs old female, Hispanic, 
Student, from Southern California,
Unexplained increase of IgG
21X UNV transaminases
Jaundiced (14X  UNV bilirubin)
ANA, SMA, AMA negative
Liver biopsy: cirrhosis
Clinical Case -2 
ReTest: 
anti-LKM
1 (1/320
)
Diagnosis
: Autoim
mune He
patitis t
ype 2
Outcome
: Liver T
ransplant
ation - D
ead
DIAGNOSIS: Cryptogenic hepatitis
They conclude that ‘ The diagnosis of type 2 AIH can be 
overlooked if anti-LKM antibody is not tested’
(they) recommend testing anti-LKM antibodies in all patients 
with a chronic liver disorder that is otherwise without 
apparent cause, especially if they are young and female.
Am J Gastroenterol 2000 Nov;95(11):3238-41 LKM-positive autoimmune hepatitis 
in the western United States: a case series. Duchini A, McHutchison JG, Pockros PJ
They also conclude that: ‘Early referral to a tertiary liver 
transplant center is appropriate in light of the complexity and 
difficulty of management of in these patients’.
Division of Gastroenterology and Hepatology, Scripps Clinic, 
La Jolla, California 92037, USA.
Am J Gastroenterol 2000 Nov;95(11):3238-41
LKM-positive autoimmune hepatitis 
in the western United States: a case series.
Duchini A, McHutchison JG, Pockros PJ
Clifford 1995 2/41 2.4%
Cassani 1997 18/290 6%
Dionysos 1999 3/226 1.3%
Iijima 2001 6/390 1.5%
Stroffolini 2004 11/502 2.2%
Monti 2005 48/2675 1.8%
LKM1 prevalence in chronic hepatitis C
2- 10 million are LKM1 positive
LKM1 prevalence in chronic hepatitis C
Of the 170 million HCV patients
Does it matter?
Iijima Y, J Gastroenterol Hepatol 2001
ALT flare in LKM1/HCV +ve pts on IFN
Gut 2000;46;553-561
Liver kidney microsomal antibody type 1 targets CYP2D6 
on hepatocyte plasma membrane
L Muratori, M Parola, A Ripalti, G Robino, P Muratori, G Bellomo,
R Carini, M Lenzi, M P Landini, E Albano and F B Bianchi
LKM1 directly pathogenic?
SLA = SEPSECS
Anti-SLA positivity is associated with:
 Longer time to achieve remission
 Tendency to relapse 
 Death or OLT
 HLA A1-B8-DR3 
 More severe histology 
 Undectable by immunofluorescence
 Laboratory is familiar with different aab patterns
 Physicians request appropriate tests and 
interpret results correctly
 Physician and laboratory talk to each other
Autoantibodies are useful if:
